Robert A Kurt
Overview
Explore the profile of Robert A Kurt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
366
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roberts M, Finn J, Lass M, Oviedo-Bermudez E, Kurt R
Immunol Invest
. 2024 May;
53(6):857-871.
PMID: 38813886
Introduction: Here, we explored methods to generate anti-tumor bone marrow-derived macrophages (BMDM) and how delivery of the BMDM at early tumor sites could impact disease progression. Methods: BMDM treated with...
2.
Chang M, Ellmaker K, Esposito A, Lauricella A, Pa S, Roberts M, et al.
Immunol Invest
. 2023 Aug;
52(7):909-924.
PMID: 37647339
Background: Previously, we reported that tumor-associated macrophages (TAM) at early sites of mammary carcinoma showed a decrease in ATP production rate and a higher dependence on oxidative phosphorylation. Methods: Since...
3.
Zhang C, Adusei M, Baranovic A, DeBenedetto M, Lauricella A, Martin S, et al.
Cell Immunol
. 2019 Sep;
346:103929.
PMID: 31495445
Here we used three different murine mammary carcinomas to study the immune environment associated with early tumor sites. While it was not surprising that the early immune response was predominated...
4.
Liew C, Phuong T, Jones C, Evans S, Hoot J, Weedling K, et al.
Comput Biol Med
. 2017 Dec;
93:56-65.
PMID: 29277001
We developed an agent-based model to simulate a signaling cascade which allowed us to focus on the behavior of each class of agents independently of the other classes except when...
5.
Higgins M, Serrano A, Boateng K, Parsons V, Phuong T, Seifert A, et al.
Breast Cancer (Auckl)
. 2016 Nov;
10:157-167.
PMID: 27812285
Previous data obtained in our laboratory suggested that there may be constitutive signaling through the myeloid differentiation primary response gene 88 (Myd88)-dependent signaling cascade in murine mammary carcinoma. Here, we...
6.
Hannum L, Kurt R, Walser-Kuntz D
Trends Immunol
. 2016 Apr;
37(7):425-426.
PMID: 27061265
Although discussions to improve training for immunologists often focus on graduate programs, there are important reasons for teaching undergraduate immunology courses and several best practices utilized by undergraduate faculty. Here,...
7.
Vrakas C, OSullivan R, Evans S, Ingram D, Jones C, Phuong T, et al.
Immunol Invest
. 2014 Sep;
44(2):174-88.
PMID: 25255046
To determine whether there was a relationship between damage associated molecular pattern molecule (DAMP) expression and recruitment of suppressor cells to sites of metastasis we measured relative expression of DAMPs,...
8.
Chalmers S, Eidelman A, Ewer J, Ricca J, Serrano A, Tucker K, et al.
Cell Immunol
. 2013 Jun;
282(2):136-45.
PMID: 23770722
Previously we reported that Myd88 contributed to tumor progression. To begin to decipher what may be inducing Myd88 dependent signaling we focused on proteins that could function as damage associated...
9.
Zhang Y, Lv D, Kim H, Kurt R, Bu W, Li Y, et al.
Cell Res
. 2012 Dec;
23(3):394-408.
PMID: 23266888
CCL5 is a member of the CC chemokine family expressed in a wide array of immune and non-immune cells in response to stress signals. CCL5 expression correlates with advanced human...
10.
Egunsola A, Zawislak C, Akuffo A, Chalmers S, Ewer J, Vail C, et al.
Cell Immunol
. 2011 Nov;
272(2):220-9.
PMID: 22088941
Previously we reported that lipopolysaccharide (LPS) treatment of murine mammary carcinomas resulted in decreased growth of the tumors. Here we show the decreased growth following LPS treatment was mediated through...